Similarly, Ramos-Mozo and colleagues [29] reported markedly decreased catalase activity levels in plasma samples obtained from 103 asymptomatic patients with small (n = 56) and large (n = 47) AAA compared to a non-AAA control cohort (n = 34). This evidence concerns the gene CAT and triple-A syndrome.